Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Methylene Blue Antiviral Treatment

NCT05004805 is registered in ClinicalTrials.gov with Irkutsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences as lead sponsor.

NCT NCT05004805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05004805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Methylene Blue Antiviral Treatment
Lead sponsor
Irkutsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences
Phase
Phase 2
Overall status
Completed
Start date
August 6, 2021
Completion date
December 12, 2021
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19